Reallocating Cervical Cancer Preventive Service Spending from Low- to High-Value Clinical Scenarios

Overview

Journal Cancer Prev Res (Phila)

Specialty Oncology

Date 2023 Mar 28

PMID 36976753

Authors

Michelle S Rockwell

Shannon D Armbruster

Jillian C Capucao

Kyle B Russell

John A Rockwell

Karen E Perkins

Alison N Huffstetler

John N Mafi

A Mark Fendrick

Affiliations

Soon will be listed here.

Abstract

Prevention Relevance: Out-of-pocket fees are a barrier to follow-up care after an abnormal cervical cancer screening test. Among commercially insured Virginians, out-of-pocket costs for follow-up services averaged $144/patient; 34% of cervical cancer screenings were classified as low value. Reallocating low-value cervical cancer screening expenditures to enhance coverage for follow-up care can improve screening outcomes. See related Spotlight, p. 363.

Citing Articles

Utilization and outcomes of serial cervical cancer screening in a National Breast and Cervical Cancer Early Detection Program (NBCCEDP) in a non-Medicaid expansion state.

Ratnaparkhi R, Ismail A, Krebill H, Cook I, Javellana M, Jewell A Cancer Causes Control. 2024; .

PMID: 39681764 DOI: 10.1007/s10552-024-01948-3.

Increased spending on low-value care during the COVID-19 pandemic in Virginia.

Rockwell M, Vangala S, Rider J, Bortz B, Russell K, Dachary M Health Aff Sch. 2024; 2(11):qxae133.

PMID: 39525276 PMC: 11549685. DOI: 10.1093/haschl/qxae133.

References

Hoagland A, Shafer P . Out-of-pocket costs for preventive care persist almost a decade after the Affordable Care Act. Prev Med. 2021; 150:106690. DOI: 10.1016/j.ypmed.2021.106690. View

Ganguli I, Morden N, Yang C, Crawford M, Colla C . Low-Value Care at the Actionable Level of Individual Health Systems. JAMA Intern Med. 2021; 181(11):1490-1500. PMC: 8477305. DOI: 10.1001/jamainternmed.2021.5531. View

Miller S, Tagai E, Wen K, Lee M, Hui S, Kurtz D . Predictors of adherence to follow-up recommendations after an abnormal Pap smear among underserved inner-city women. Patient Educ Couns. 2017; 100(7):1353-1359. PMC: 5466500. DOI: 10.1016/j.pec.2017.01.020. View

Blanco M, Chen L, Melamed A, Tergas A, Khoury-Collado F, Hou J . Cost of care for the initial management of cervical cancer in women with commercial insurance. Am J Obstet Gynecol. 2020; 224(3):286.e1-286.e11. DOI: 10.1016/j.ajog.2020.08.039. View

Wright J, Chen L, Tergas A, Melamed A, St Clair C, Hou J . Overuse of Cervical Cancer Screening Tests Among Women With Average Risk in the United States From 2013 to 2014. JAMA Netw Open. 2021; 4(4):e218373. PMC: 8085723. DOI: 10.1001/jamanetworkopen.2021.8373. View

Eggleston K, Coker A, Das I, Cordray S, Luchok K . Understanding barriers for adherence to follow-up care for abnormal pap tests. J Womens Health (Larchmt). 2007; 16(3):311-30. DOI: 10.1089/jwh.2006.0161. View

Cliff B, Avancena A, Hirth R, Lee S . The Impact of Choosing Wisely Interventions on Low-Value Medical Services: A Systematic Review. Milbank Q. 2021; 99(4):1024-1058. PMC: 8718584. DOI: 10.1111/1468-0009.12531. View

Mafi J, Reid R, Baseman L, Hickey S, Totten M, Agniel D . Trends in Low-Value Health Service Use and Spending in the US Medicare Fee-for-Service Program, 2014-2018. JAMA Netw Open. 2021; 4(2):e2037328. PMC: 7887655. DOI: 10.1001/jamanetworkopen.2020.37328. View

Norris H, Richardson H, Benoit M, Shrosbree B, Smith J, Fendrick A . Utilization Impact of Cost-Sharing Elimination for Preventive Care Services: A Rapid Review. Med Care Res Rev. 2021; 79(2):175-197. DOI: 10.1177/10775587211027372. View

10.

Mafi J, Russell K, Bortz B, Dachary M, Hazel Jr W, Fendrick A . Low-Cost, High-Volume Health Services Contribute The Most To Unnecessary Health Spending. Health Aff (Millwood). 2017; 36(10):1701-1704. PMC: 6727655. DOI: 10.1377/hlthaff.2017.0385. View

11.

Barthold D, Yeung K, Lieberman D, Fendrick A . Comparison of Screening Colonoscopy Rates After Positive Noninvasive Testing for Colorectal Cancer in States With and Without Cost-Sharing. JAMA Netw Open. 2022; 5(6):e2216910. PMC: 9198727. DOI: 10.1001/jamanetworkopen.2022.16910. View

12.

Qin J, Holt H, Richards T, Saraiya M, Sawaya G . Use Trends and Recent Expenditures for Cervical Cancer Screening-Associated Services in Medicare Fee-for-Service Beneficiaries Older Than 65 Years. JAMA Intern Med. 2022; 183(1):11-20. PMC: 9679959. DOI: 10.1001/jamainternmed.2022.5261. View

13.

Curry S, Krist A, Owens D, Barry M, Caughey A, Davidson K . Screening for Cervical Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2018; 320(7):674-686. DOI: 10.1001/jama.2018.10897. View

14.

Kim D, Daly A, Koethe B, Fendrick A, Ollendorf D, Wong J . Low-Value Prostate-Specific Antigen Test for Prostate Cancer Screening and Subsequent Health Care Utilization and Spending. JAMA Netw Open. 2022; 5(11):e2243449. PMC: 9682424. DOI: 10.1001/jamanetworkopen.2022.43449. View

15.

Biddell C, Spees L, Smith J, Brewer N, Des Marais A, Sanusi B . Perceived Financial Barriers to Cervical Cancer Screening and Associated Cost Burden Among Low-Income, Under-Screened Women. J Womens Health (Larchmt). 2021; 30(9):1243-1252. PMC: 8558088. DOI: 10.1089/jwh.2020.8807. View

16.

Oakes A, Boyce K, Patton C, Jain S . Rates of Routine Cancer Screening and Diagnosis Before vs After the COVID-19 Pandemic. JAMA Oncol. 2022; 9(1):145-146. PMC: 9673020. DOI: 10.1001/jamaoncol.2022.5481. View

17.

Bouck Z, Calzavara A, Ivers N, Kerr E, Chu C, Ferguson J . Association of Low-Value Testing With Subsequent Health Care Use and Clinical Outcomes Among Low-risk Primary Care Outpatients Undergoing an Annual Health Examination. JAMA Intern Med. 2020; 180(7):973-983. PMC: 7281357. DOI: 10.1001/jamainternmed.2020.1611. View

18.

Kepka D, Breen N, King J, Benard V, Saraiya M . Overuse of papanicolaou testing among older women and among women without a cervix. JAMA Intern Med. 2013; 174(2):293-6. PMC: 4386596. DOI: 10.1001/jamainternmed.2013.12607. View

19.

Haas J, Sprague B, Klabunde C, Tosteson A, Chen J, Bitton A . Provider Attitudes and Screening Practices Following Changes in Breast and Cervical Cancer Screening Guidelines. J Gen Intern Med. 2015; 31(1):52-9. PMC: 4700005. DOI: 10.1007/s11606-015-3449-5. View

20.

Fendrick A, Dalton V, Tilea A, Malone A, Moniz M . Out-of-Pocket Costs for Colposcopy Among Commercially Insured Women From 2006 to 2019. Obstet Gynecol. 2021; 139(1):113-115. PMC: 8667797. DOI: 10.1097/AOG.0000000000004582. View